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Abstract: Alzheimer’s disease (AD) is an age-related neurodegenerative disorder associated with neurochemical and 
neurobehavioural alterations. Aluminium (Al) is considered as a contributing factor in the etiology of several 
neurodegenerative disorders like AD. D-galactose (D-gal) is a physiological nutrient but over supply induces some 
neurochemical and biochemical changes that exacerbate natural aging process. In this study, we aimed to develop AD 
animal model by co-administration of Al and D-gal in rats. Male albino Wistar rats were intraperitoneally injected with 
AlCl3 and D-gal at a dose of 150mg/kg and 300mg/kg respectively for one week. After one week rats were subjected to 
behavioural analysis. After behavioural analysis rats were decapitated to remove their brain. Biochemical and 
neurochemical analysis were conducted in whole brain. AlCl3+D-gal significantly induced depressive and anxious 
behaviour in rats. Rats cognitive abilities were also significantly impaired following AlCl3 and D-gal co-administration. 
AlCl3+D-gal significantly altered antioxidant enzyme activities and biogenic amine levels in whole brain. A marked 
increase in brain lipid peroxidation and acetylcholinesterase activity was found in test rats. These findings suggest that 
co-administration of AlCl3 and D-gal for one week could induce AD like symptoms and may be used to develop AD 
animal model. 
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INTRODUCTION 
 
Alzheimer’s disease (AD) is the most common and 
gradually progressing neurodegenerative disorder 
characterized by alterations in brain structure and 
functions, starting from mild cognitive dysfunctions and 
ending with severe brain damage (Mahdi et al., 2006). 
The characteristic symptoms observed in AD include a 
progressive decline in cognitive functions and behavioural 
alterations such as difficulties in learning and memory, 
confusion and agitation (Parsons et al., 2013). Many 
environmental, genetic and physiological factors have 
been implicated in the pathology of AD (Zatta et al., 
2002). Aluminium (Al) is considered as a contributing 
factor in the progression of several neurodegenerative 
disorders like AD (Bitra et al., 2014). Along with neuritic 
deposits, plaques and neurofibrillary tangles elevated 
levels of Al have also been observed in AD brain 
(McLachlan et al., 1991). Acidification of environment 
including usage of chemical fertilizers in agriculture areas 
and water pollution due to discharge of industrial wastage 
increases Al bioavailability (Dave et al., 2002). A variety 
of human and animal studies suggested that Al 
accumulation increases with age and retained in the brain 
(Good et al., 1992) which may be due to either excess of 
exposure or decreased ability to remove Al from the brain 
(Dave et al., 2002). A number of evidence have indicated 
that increased Al accumulation in brain may lead to free 
radical generation and thereby result in the pathology of 
several neurodegenerative disorders such as AD (Abu-
taweel et al., 2012). Al causes promotion and 
accumulation of insoluble amyloid-β (Aβ) protein and 
aggregation of hyperphosphorylated tau protein which is a 
characteristic indication of neurodegeneration associated 
with AD (Kumar et al., 2009). D-galactose (D-gal) is a 
physiological nutrient and a normal reducing sugar in 
body. D-galactokinase and galactose-1-phosphate uridyl 
transferase normally metabolize galactose, but long term 
exposure or over supply results in its abnormal 
metabolism (Haider et al., 2015). Increased D-gal 
undergoes oxidation processes eventually resulting in 
production of aldose and hyperoxide radicals through the 
action of galactose oxidase. Oxidation of D-gal leads to 
the formation of super oxide anions and other oxygen-
derived free radicals that cannot be further metabolized 
and may get accumulated in the cell resulting in 
production of reactive oxygen species (ROS) (Wu et al., 
2008). ROS induced neurotoxicity can exacerbates natural 
aging process and produces cognitive impairment (Dufour 
and Larsson, 2004). Brain aging is a threat for many 
neurodegenerative disorders such as Alzheimer’s disease 
and Parkinson’s disease (Cui et al., 2006). We have *Corresponding author: e-mail: saida-h1@hotmail.com  
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previously shown that D-gal at a dose of 300mg/ml/kg for 
one week could induce alterations in biochemical, 
neurochemical and neurobehavioral parameters, 
simulating natural aging process and could be used to 
develop an aging animal model (Haider et al., 2015). D-
gal mimic natural aging process while Al promotes 
neurodegeneration by acting as a neurotoxin so their co-
administration may result in pathological changes that are 
associated with AD. With the aim of gaining better 
understanding of neurodegenerative mechanism of AD, 
our purpose of study was to evaluate the short term effects 
of co-administration of AlCl3 and D-gal at a dose of 
150mg/kg and 300mg/kg respectively in rats in order to 
develop an AD animal model that could be further utilized 
for studying neurodegenerative processes associated with 
AD. 
 
MATERIALS AND METHODS 
 
Experimental protocol 
Sixteen locally bred young adult male Albino Wistar rats 
weighing 100-150g were used in the present study. Rats 
were randomly divided into two groups (n=8): group 1: 
assigned as control where as group 2: assigned as test. 
AlCl3 and D-gal were dissolved in physiological saline 
(0.9%) and were freshly prepared at the beginning of each 
experiment. Rats in test group were intraperitoneally (i.p) 
injected with AlCl3 and D-gal at a dose of 150 mg/kg and 
300 mg/kg respectively for one week, while rats of the 
control group received equivalent volume of 0.9% saline. 
24h after the last injection rats were subjected to 
behavioural analysis and 24h after the last behaviour rats 
were decapitated to collect their brain for further 
biochemical and neurochemical analysis. Each 
experiment was conducted in a balance designed with 
proper conditions and responses were evaluated in a quiet 
fixed schedule to avoid time and order effect. 
 
Behavioural analysis 
Anxiety of rats was assessed with the help of light dark 
transition (LDT) test, number of entries and time spent in 
light compartment was monitored. Forced swim test 
(FST) was used to assess depression like symptoms in rats 
by monitoring immobility time. Working memory of rats 
was assessed by Morris water maze (MWM) test, passive 
avoidance test (PAT) and elevated plus maze (EPM) test. 
In MWM escape latency was monitored. Step through 
latency was monitored in PAT. In EPM transfer latency 
was monitored. The assessment of exploratory activity 
was performed by using open field test (OFT) in which 
number of squares crossed by rats were monitored, as 
described previously (Haider et al., 2015). 
 
Biochemical estimations 
Estimation of lipid peroxidation (LPO) was performed as 
described by Chow and Tappel (1972) with slight 
modifications (Haider et al., 2015) in terms of 
malondialdehyde (MDA) levels and was presented as 
µmoles of MDA/g of brain. Brain superoxide dismutase 
(SOD) activity was estimated by the method of 
Chidambara et al (2002). Activity of SOD was presented 
as U/g of brain. Catalase (CAT) activity was assessed as 
described by Sinha (1972). CAT activity was presented as 
consumption of H2O2 µmol/min/g of brain. Glutathione 
peroxidase (GPx) activity was determined by the 
procedure of Flohe and Gunzler (1984). Activity of GPx 
was presented as µmol/min/g of brain. 
 
Fig. 1: Oxidative stress status of AlCl3+D-gal treated and 
control group rats. Effect of AlCl3+D-gal administration 
on antioxidant enzymes activities including superoxide 
dismutase (SOD) (U/g of brain tissue), catalase (CAT) 
(µmol/min/g of brain tissue), glutathione peroxidase 
(GPx) (µmol/min/g of brain tissue) and lipid peroxidation 
in terms of malondialdehyde (MDA) levels (µmol/g of 
brain tissue). Values are mean ± SEM (n=8). Mean 
differences for each group were evaluated by an 
independent sample t-test. Statistical difference is 
represented as *P<0.01. 
 
Neurochemical estimations 
Acetylcholinesterase (AChE) activity in the whole brain 
was estimated as described by Ellman et al. (1961). The 
activity of AChE was presented as µmol/min/g of brain. 
The neurochemical analysis was done to assess 
concentrations of brain biogenic amines as described by 
Haider et al. (2014). 
 
STATISTICAL ANALYSIS 
 
Data are presented as mean ± SEM (n=8). Mean 
differences for each group were evaluated by an 
independent sample t-test via SPSS version 17.0 software 
and values of p0.01 were defined as statistically 
significant. Correlation analysis was performed via SPSS 
by using Pearson's correlation test. 
 
RESULTS 
 
Effect of co-administration of AlCl3 and D-gal on 
behaviours 
Data presented in table 1 indicates the effects of co-
administration of AlCl3 and D-gal on behaviours. Test 
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group rats exhibited significant (p0.01) reduced 
numbers of entries and time spent in the light 
compartment as compared to control rats suggesting an 
anxiogenic effect of AlCl3+D-gal administration. 
AlCl3+D-gal treated rats exhibited a significant increased 
(p0.01) immobility time in FST as compared to control 
rats. Increased immobility time showed depressogenic 
behaviour in test rats. Rats treated with AlCl3+D-gal 
showed increased exploratory activity (p0.01) as 
indicated by increased number of square crossed in OFT 
as compared to control rats. In MWM AlCl3+D-gal 
treated rats exhibited a significant (p0.01) increase in 
escape latency during the test session as compared to 
control. AlCl3+D-gal treated rats showed significant 
(p0.01) increased transfer latency as compared to 
control rats in EPM. The step through latency in PAT was 
significantly (p0.01) decreased following AlCl3+D-gal 
administration for one week than those of the control rats. 
 
Effect of co-administration of AlCl3 and D-gal on brain 
lipid peroxidation (LPO) and antioxidant enzyme 
activities 
Fig. 1 describes oxidative stress status of control and 
Al+D-gal treated rats. One week co-administration of 
Table 1: Effects of co-administration of AlCl3 and D-gal on behaviours light dark transition (LDT), forced swim test 
(FST), open field test (OFT), Morris water maze (MWM) test, elevated plus maze (EPM) test, passive avoidance test 
(PAT). Values are mean ± SEM (n=8). Mean differences for each group were evaluated by an independent sample t-
test. Statistical difference is represented as *P<0.01. 
 
Behaviours Parameters Control Al+D-gal t-Values 
LDT Time Spent (sec) 74.08± 5.72 s 40.71±7.40 s* 6.000 Number of Entries 3.42±0.49 2.14±0.34* 10.069 
FST Immobility Time (sec) 77.27±6.24 s 97.98±8.58 s* 5.517 
OFT Number of Square Crossed 53.35±7.75 67.08±8.96* 3.276 
MWM Escape Latency (sec) 17.85±2.67 s 49.62±5.58 s* 14.522 
EPM Transfer Latency (sec) 38.22±8.63 s 60.10±5.28 s* 6.110 
PAT Step through Latency (sec) 173.14±8.54 s 154.17±6.79 s* 4.916 
 
 
Fig. 2: The Pearson correlation between oxidative marker malondialdehyde and antioxidant enzymes. Correlation was 
performed by using Pearson's correlation test. Correlation of (a) SOD, (b) CAT and (c) GPx with MDA levels. 
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AlCl3 and D-gal significantly altered the antioxidant 
enzyme activities. SOD activity was significantly 
increased in the test group (28.60±2.60U/g) compared 
with control rats (23.36±0.85U/g) (p0.01). CAT (42.05± 
6.79µmol/min/g) and GPx (12.31±2.27µmol/ min/g) 
activities were significantly (p0.01) decreased in the test 
group as compared to control rats (CAT=68.56±2.43 
µmol/min/g; GPx=86.68±1.86µmol/ min/g). AlCl3+D-gal 
treated rats (38.46±2.67 µmol/g) showed a significant 
increase in MDA levels (p0.01) compared with control 
rats (25.43±2.54µmol/g). Pearson correlation analysis fig. 
2(a-c) between oxidative stress marker MDA and 
antioxidant enzymes revealed that the activities of CAT 
(r=-0.915, p<0.01) and GPx (r=-0.939, p<0.01) were 
negatively correlated with MDA levels, while the activity 
of SOD (r=0.682, p<0.01) was positively correlated with 
MDA levels. 
 
Effect of co-administration of AlCl3 and D-gal on brain 
acetylcholinesterase (AChE) activity and biogenic amine 
levels 
AChE activity was significantly (p<0.01) increased in the 
brain of AlCl3+D-gal treated rats (3678.04±252.40 
µmol/min/g) as compared to control rats (2627.40± 
162.79µmol/min/g) as shown in fig. 3. Data in fig. 4(a) 
shows the chromatogram of standard solution containing 
biogenic amines noradrenaline (NA), dihydroxyphenyl 
acetic acid (DOPAC), dopamine (DA), 5-
hydroxyindoleacetic acid (5-HIAA), homovanillic acid 
(HVA) and 5-hydroxytryptamine (5-HT) whereas fig. 4(b) 
shows the chromatogram of biogenic amines in the whole 
brain of control rats and AlCl3+D-gal treated rats. The 
results of neurochemical estimation in fig. 4(c) shows the 
changes in whole brain biogenic amine levels. AlCl3+D-
gal administration also reduced 5-HT (176.28± 
31.56ng/g) and 5-HIAA (126.46±25.36ng/g) (p<0.01) 
levels in whole brain of the test rats when compared to 
control rats 5-HT (274.28±26.561ng/g), 5-HIAA 
(312.26±58.56ng/g). The DA (124.65±13.0ng/g) and 
DOPAC (153.75±15.90ng/g) levels in the test rats showed 
a significant decline (p<0.01) as compared to control rats 
DA (413.11±60.162ng/g), DOPAC (423.58± 46.79ng/g). 
 
DISCUSSION 
 
The results of present study demonstrate that co-
administration of AlCl3 and D-gal results in marked 
impairment of working memory as indicated by increase 
in retention latencies as compared to the control group in 
both MWM and EPM. Cognitive dysfunction and 
behavioural alteration by Al have been reported in a 
number of studies (Gong et al., 2006; Abu-taweel et al., 
2012). The results of the present study indicated that co-
administration of AlCl3 and D-gal to rats significantly 
deteriorates working memory in MWM. This memory 
deterioration was also observed in PAT and EPM. 
AlCl3+D-gal treatment showed depression like symptoms 
as indicated by increased immobility time in test rats 
compared to control rats in FST. AlCl3+D-gal injected rats 
also exhibited anxiogenic behaviour in LDT. Anxiety and 
depression are the most common neuropsychiatric 
conditions observed in AD patients (Teri et al., 1999) 
these observations are consistent with our results. 5-HT is 
known to be involved in many psychological conditions 
such as depression, anxiety, aggression or psychosis. 
Previous reports have shown extensive serotonergic 
denervation in AD and reduced serotonergic functions 
have been associated with aggressive behaviour (Lancot 
et al., 2001). Consistent with the previous reports in our 
study following AlCl3+D-gal treatment 5-HT and its 
metabolite 5-HIAA levels were altered in whole brain of 
test rats as compared to control rats, possible cause of 
depressive and anxiogenic behaviour in rats. Decrease 5-
HT levels in brain may result in up regulation of 
serotonergic receptors leading to anxiogenic like 
behaviour (Nutt et al., 1999). AlCl3+D-gal injected rats 
also showed hyperactivity in OFT. Hyperactivity is 
associated with stress conditions as rats feel anxious in an 
unfamiliar or novel environment (Rebai and Djebli, 
2008). 
 
Fig. 3: Brain acetylcholinesterase (AChE) activity 
(µmol/min/g of brain tissue) was measured in control and 
test rats. Values are mean ± SEM (n=8). Mean differences 
for each group were evaluated by an independent sample 
t-test. Statistical difference is represented as *P<0.01. 
 
Short term memory is generally associated with the levels 
of acetylcholine (ACh) in brain, as depletion in ACh 
levels is closely related to dementia (Amberla et al., 
1993). The determination of key enzymes of cholinergic 
system such as AChE is used to indirectly reflect ACh 
levels (Gong et al., 2006). In our study AlCl3+D-gal 
treatment resulted in marked increase in AChE activity. 
This increase in AChE activity may be due to the genetic 
over expression of AChE by oxidative stress produced by 
D-gal (Zhong et al., 2009) while increased AChE activity 
following AlCl3 administration may be due to allosteric 
interaction between the cation and peripheric anionic site 
of the enzyme may further results in enhanced AChE 
Laraib Liaquat et al 
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activity (Gulya et al., 1990). So their combined effect 
results in marked increased in AChE activity. These 
cholinergic deficiencies may also be linked to the 
neuropsychiatric aspects of the present study, as clinical 
observations suggest an important link between 
neuropsychological impairments observed in AD and 
cholinergic dysfunctions (Cummings and Kaufer, 1996). 
AChE activity was also correlated with escape latency, 
and a positive correlation was found and hence the 
resulted cognitive dysfunctions observed in present study 
may be strongly related to AChE activity. 
 
In the present study combined treatment of AlCl3 and D-
gal leads to decline levels of 5-HT, 5-HIAA, DA and 
DOPAC in whole brain of test rats as compared to control 
rats. Aging has been associated with declined levels of 
DA and 5-HT and their metabolites in hippocampus, 
cortex and whole brain (Haider et al., 2014). 
Psychological alterations and decline in cholinergic and 
serotonergic functions are excessively reported in aged 
and AD patients (Cummings and McPherson, 2001).This 
is parallel with our neurochemical results and also with 
our behavioural observations. A significant decline in 
5HT, DA and their metabolites was observed in whole 
brain of rats treated with combination of AlCl3 and D-gal 
compared to control rats. The deposition of Aβ plaques in 
brain is the characteristic pathological feature of AD. It 
has been shown that combined treatment of AlCl3 and D-
gal caused remarkable alterations in the expression of Aβ 
metabolism-associated protein and has a stronger effect 
on Aβ deposition (Luo et al., 2009). Deposition of plaques 
and tangles induce neuronal dysfunction and destruction 
of synapse and neurons that eventually results in deprived 
neurotransmission (Mesulam, 1996). Taken together this 
could explain neurochemical dysfunctions and 
behavioural alterations observed in the present study. 
 
Fig. 4: (a) HPLC chromatogram showing the retention time of noradrenaline (NA), dihydroxyphenyl acetic acid 
(DOPAC), dopamine (DA), 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and 5-hydroxytryptamine 
(5-HT) in standard solution and (b) whole brain of rats treated with saline and AlCl3+D-gal (c) estimated levels of 
biogenic amines in whole brain of the control and test rats (**P<0.01). Values are mean ± SEM (n=8). Mean 
differences for each group were evaluated by an independent sample t-test. Statistical difference is represented as 
*P<0.01. 
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Although histopathological studies were not done in the 
present study but observed changes may be correlated 
with plaques and tangles associated neurodegeneration. 
 
We further investigated the mechanism involved in the 
deleterious effects of co-administration of AlCl3 and D-
gal on antioxidant defense system. Increased LPO results 
in neuronal damage and may lead to neurodegenerative 
disorders like Alzheimer’s and Parkinson’s disease 
(Kaizer et al., 2005). Under the oxidative stress 
conditions, SOD attacks first by converting overloaded 
superoxide (O2 -) radicals to hydrogen peroxide radicals 
(H2O2). These H2O2 radicals further scavenged by GPx 
and CAT result in production of water and molecular 
oxygen (Naidu et al., 2013; Haider et al., 2015). The free 
radical scavenging properties of SOD is only 
advantageous when it is proceeds by the scavenging 
activity of GPx and CAT (Bhattacharya et al., 2001). 
Excess of SOD with decrease CAT and GPx activity is 
known to have destructive tissue effects (Blake et al., 
1987). MDA is widely used as oxidative stress biomarker, 
which is formed as an end product of LPO induced by 
free radicals (Cui et al., 2006). In the present study one 
week co-administration of AlCl3 and D-gal to rats caused 
significant increased in oxidative stress. Following AlCl3 
and D-gal administration an increase in LPO in terms of 
MDA levels, increase in SOD activity with reduced 
activities of CAT and GPx was observed in the brain of 
test rats as compared to control rats. Enhanced LPO may 
interfere with cholinergic pathways possibly causing 
cholinergic dysfunction and leads to learning and memory 
impairment (Kaizer et al., 2005). The results of the 
present study showed that combination of AlCl3 and D-gal 
has more toxic effects on antioxidant defense system and 
promote ROS induced oxidative damage. Activities of 
SOD, CAT and GPx were also correlated with MDA 
levels. A positive correlation was found between SOD and 
MDA levels whereas negative correlation was found 
between GPx and MDA levels and CAT and MDA levels 
in AlCl3 and D-Gal treated rats. 
 
CONCLUSION 
 
Although AlCl3 and D-gal work through their own 
pathways but eventually result in similar pathological 
conditions and symptoms observed in AD. Present 
findings suggest that combined administration of AlCl3 
and D-gal for one week could induce AD like symptoms 
and may produce neurochemical and neurobehavioral 
alterations similar to AD. Hence co-administration of 
AlCl3 and D-gal would produce an ideal AD animal 
model for understanding the underlying mechanism 
involved with neurodegenerative alteration in AD brain. 
This AD animal model may be more appropriate choice to 
understand pathogenesis, diagnosis, prevention and even 
treatment of AD in future studies as it is less time 
consuming and inexpensive. 
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